Prostate cancer
Medicine & Biotech · covered by 29 outlets this week · tracked since 2026-10-27
Press: 9 mainstream 38 specialist 29 independent outlet-days
What it is
Prostate cancer is the most common cancer in men in many countries, often slow-growing and found by PSA blood tests, sometimes aggressive. It is in the news because screening advice is shifting, because active surveillance has replaced surgery for many low-risk cases, and because radioligand therapy and new hormonal drugs are extending survival in advanced disease. The central debate is overdiagnosis: PSA finds cancers that would never have caused harm, so guidelines ask men to weigh the trade-off with a doctor.
Written by the Alivewire editors from the coverage below, 1d ago. Not medical advice; how the ratings work.
Coverage